+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Pruritus Therapeutic Market 2021-2025- Product Image
Global Pruritus Therapeutic Market 2021-2025- Product Image

Global Pruritus Therapeutic Market 2021-2025

  • ID: 5017675
  • Report
  • June 2021
  • Region: Global
  • 120 pages
  • TechNavio

FEATURED COMPANIES

  • AbbVie Inc.
  • Amgen Inc.
  • Cipla Inc.
  • GlaxoSmithKline Plc
  • Johnson and Johnson Inc.
  • Maruho Co. Ltd.
  • MORE
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher has been monitoring the pruritus therapeutics market and it is poised to grow by $ 4.01 bn during 2021-2025, progressing at a CAGR of almost 6% during the forecast period. The report on the pruritus therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of pruritus and the growing demand for drug-induced pruritus.

The pruritus therapeutics market analysis includes the type segment and geographic landscape.

The pruritus therapeutics market is segmented as below:


By Type

  • Renal pruritus
  • Cholestatic pruritus
  • Hematologic pruritus
  • Endocrine pruritus
  • Oncological pruritus

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • ROW
This study identifies the strong pipeline of expected launches as one of the prime reasons driving the pruritus therapeutics market growth during the next few years.

The report on pruritus therapeutics market covers the following areas:

  • Pruritus therapeutic market sizing
  • Pruritus therapeutic market forecast
  • Pruritus therapeutic market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pruritus therapeutics market vendors that include AbbVie Inc., Amgen Inc., Cipla Inc., GlaxoSmithKline Plc, Johnson and Johnson Inc., Maruho Co. Ltd., Novartis AG, Pfizer Inc., Sanofi SA, and Sun Pharmaceutical Industries Ltd. Also, the pruritus therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AbbVie Inc.
  • Amgen Inc.
  • Cipla Inc.
  • GlaxoSmithKline Plc
  • Johnson and Johnson Inc.
  • Maruho Co. Ltd.
  • MORE

Executive Summary

  • Market overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Disease type

  • Market segments
  • Comparison by Disease type
  • Renal pruritus - Market size and forecast 2020-2025
  • Cholestatic pruritus - Market size and forecast 2020-2025
  • Hematologic pruritus - Market size and forecast 2020-2025
  • Endocrine pruritus - Market size and forecast 2020-2025
  • Oncological pruritus - Market size and forecast 2020-2025

Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity By Geographical Landscape
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • AbbVie Inc.
  • Amgen Inc.
  • Cipla Inc.
  • GlaxoSmithKline Plc
  • Johnson and Johnson Inc.
  • Maruho Co. Ltd.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibits

  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2020 - 2025 ($ million)
  • Global market: Year-over-year growth 2020 - 2025 (%)
  • Five forces analysis 2020 & 2025
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2020
  • Other1 - Market share 2020-2025 (%)
  • Comparison by Other1
  • Renal pruritus - Market size and forecast 2020-2025 ($ million)
  • Renal pruritus - Year-over-year growth 2020-2025 (%)
  • Cholestatic pruritus - Market size and forecast 2020-2025 ($ million)
  • Cholestatic pruritus - Year-over-year growth 2020-2025 (%)
  • Hematologic pruritus - Market size and forecast 2020-2025 ($ million)
  • Hematologic pruritus - Year-over-year growth 2020-2025 (%)
  • Endocrine pruritus - Market size and forecast 2020-2025 ($ million)
  • Endocrine pruritus - Year-over-year growth 2020-2025 (%)
  • Oncological pruritus - Market size and forecast 2020-2025 ($ million)
  • Oncological pruritus - Year-over-year growth 2020-2025 (%)
  • Market opportunity by Other1
  • Customer landscape
  • Market share By Geographical Landscape 2020-2025 (%)
  • Geographic comparison
  • North America - Market size and forecast 2020-2025 ($ million)
  • North America - Year-over-year growth 2020-2025 (%)
  • Europe - Market size and forecast 2020-2025 ($ million)
  • Europe - Year-over-year growth 2020-2025 (%)
  • Asia - Market size and forecast 2020-2025 ($ million)
  • Asia - Year-over-year growth 2020-2025 (%)
  • ROW - Market size and forecast 2020-2025 ($ million)
  • ROW - Year-over-year growth 2020-2025 (%)
  • Key leading countries
  • Market opportunity By Geographical Landscape ($ million)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • AbbVie Inc. - Overview
  • AbbVie Inc. - Product and service
  • AbbVie Inc. - Key offerings
  • AbbVie Inc. - Key customers
  • AbbVie Inc. - Segment focus
  • Amgen Inc. - Overview
  • Amgen Inc. - Business segments
  • Amgen Inc. - Key offerings
  • Amgen Inc. - Key customers
  • Amgen Inc. - Segment focus
  • Cipla Inc. - Overview
  • Cipla Inc. - Business segments
  • Cipla Inc. - Key offerings
  • Cipla Inc. - Key customers
  • Cipla Inc. - Segment focus
  • GlaxoSmithKline Plc - Overview
  • GlaxoSmithKline Plc - Business segments
  • GlaxoSmithKline Plc - Key offerings
  • GlaxoSmithKline Plc - Key customers
  • GlaxoSmithKline Plc - Segment focus
  • Johnson and Johnson Inc. - Overview
  • Johnson and Johnson Inc. - Business segments
  • Johnson and Johnson Inc. - Key offerings
  • Johnson and Johnson Inc. - Key customers
  • Johnson and Johnson Inc. - Segment focus
  • Maruho Co. Ltd. - Overview
  • Maruho Co. Ltd. - Product and service
  • Maruho Co. Ltd. - Key offerings
  • Maruho Co. Ltd. - Key customers
  • Maruho Co. Ltd. - Segment focus
  • Novartis AG - Overview
  • Novartis AG - Business segments
  • Novartis AG - Key offerings
  • Novartis AG - Key customers
  • Novartis AG - Segment focus
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Business segments
  • Pfizer Inc. - Key offerings
  • Pfizer Inc. - Key customers
  • Pfizer Inc. - Segment focus
  • Sanofi SA - Overview
  • Sanofi SA - Business segments
  • Sanofi SA - Key offerings
  • Sanofi SA - Key customers
  • Sanofi SA - Segment focus
  • Sun Pharmaceutical Industries Ltd. - Overview
  • Sun Pharmaceutical Industries Ltd. - Business segments
  • Sun Pharmaceutical Industries Ltd. - Key offerings
  • Sun Pharmaceutical Industries Ltd. - Key customers
  • Sun Pharmaceutical Industries Ltd. - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AbbVie Inc.
  • Amgen Inc.
  • Cipla Inc.
  • GlaxoSmithKline Plc
  • Johnson and Johnson Inc.
  • Maruho Co. Ltd.
  • MORE
The publisher recognizes the following companies as the key players in the global pruritus therapeutics market: AbbVie Inc., Amgen Inc., Cipla Inc., GlaxoSmithKline Plc, Johnson and Johnson Inc., Maruho Co. Ltd., Novartis AG, Pfizer Inc., Sanofi SA, and Sun Pharmaceutical Industries Ltd.

Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is a strong pipeline of expected launches.`

According to the report, one of the major drivers for this market is the increasing prevalence of pruritus.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • AbbVie Inc.
  • Amgen Inc.
  • Cipla Inc.
  • GlaxoSmithKline Plc
  • Johnson and Johnson Inc.
  • Maruho Co. Ltd.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll